Urothelial Bladder Cancer clinical trials

Explore recruiting urothelial bladder cancer clinical trials.

Recruiting urothelial bladder cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Urothelial Bladder Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 clinical study to assess efficacy of Induction ipilimumab/nivolumab to spare the Bladder in urothelial bladder cancer (Indi-Blade)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of BI 907828 for treatment of patients with locally advanced / metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours

Spain, France, Belgium, Germany, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy of IO102-IO103 in Combination with Pembrolizumab, as First-line Treatment for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of Head and Neck (SCCHN), or Metastatic Urothelial Bladder Cancer (mUBC)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Urothelial Bladder Cancer trials by city

Urothelial Bladder Cancer in Toronto Urothelial Bladder Cancer in Vancouver Urothelial Bladder Cancer in Montreal Urothelial Bladder Cancer in Calgary Urothelial Bladder Cancer in Edmonton Urothelial Bladder Cancer in Ottawa Urothelial Bladder Cancer in Winnipeg Urothelial Bladder Cancer in Quebec City Urothelial Bladder Cancer in Hamilton Urothelial Bladder Cancer in Kitchener Urothelial Bladder Cancer in London Urothelial Bladder Cancer in Halifax Urothelial Bladder Cancer in New York Urothelial Bladder Cancer in Los Angeles Urothelial Bladder Cancer in Chicago Urothelial Bladder Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease